Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

Details for Australian Patent Application No. 2005267421 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Maccoss, Malcolm; Olsen, David B.

Agent Spruson & Ferguson

Pub. Number AU-B-2005267421

PCT Pub. Number WO2006/012078

Priority 60/619,746 18.10.04 US; 60/582,667 24.06.04 US

Filing date 20 June 2005

Wipo publication date 2 February 2006

Acceptance publication date 3 June 2010

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/012078 Priority application(s): WO2006/012078

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

3 June 2010 Application Accepted

  Published as AU-B-2005267421

30 September 2010 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267423-Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases

2005267419-Production of valve metal powders with improved physical and electrical properties